3Tasaka K. Epinastine: An update of its pharmacology, metabolism, Cli- nical efficacy and tolerability in the treament of allergic diseases. Drugs Today (Barc) 2000;36: 735 - 757.
2Tasaka K. Epinstine: An update of its pharmacology, metabolism,clinical efficacy and tolerability in the treatment of allergic diseases[J]. Drugs Today,2000,36(11) :735.
3Tasaka K.Epinastine:An update of its pharmacology,metabolism,clinical efficacy and tolerability in the treatment of allergic diseases.Drugs Today (Barc),2000,36:735-757.
4Grant JA,Danielson L,Rihoux JP,et al.A double-blind,single-dose,crossover comparison of cetirizine,ebastine,epinastine,fexofenadine,terfenadine,and loratadine versus placebo:suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.Allergy,1999,54:700-707.
